Department of Chemistry, College of Science, King Faisal University, Hofuf, Saudi Arabia.
Drug Test Anal. 2011 Jun;3(6):380-6. doi: 10.1002/dta.277. Epub 2011 Mar 30.
Sequential injection analysis (SIA) technique with a miniaturized fibre optic spectrophotometry was exploited to optimize and validate a new method for the assay of verapamil in pharmaceutical formulations. The reduction of acidified permanganate by verapamil was spectrophotometrically detected at 546 nm. The 2(3) full-factorial design was adopted for screening the effect of conditions controlling the proposed method, and accordingly for the purpose of optimization. The remarkable advantages of the method are high rapidity (sample frequency was 10.6 samples/h), saving in reagents and sample (total consumed volume was 190 µl) and better safety for the environment (total waste production volume was 2140 µl). Additionally, the method was selective in the presence of excipients usually found in tablet and injection formulations. The average of recovery in synthetic samples as well as dosage forms was 98.8-103.0%. The obtained results were realized by the British Pharmacopoeia method and comparable results were obtained.
采用微型光纤分光光度法的顺序注射分析(SIA)技术,优化并验证了一种新的药物制剂中维拉帕米测定方法。在 546nm 处,通过酸性高锰酸盐还原法对维拉帕米进行分光光度检测。采用 2(3)完全析因设计筛选控制所提出方法的条件的影响,从而达到优化的目的。该方法的显著优点是快速(样品频率为 10.6 个/小时)、节省试剂和样品(总消耗量为 190µl),并且对环境更安全(总废物产生量为 2140µl)。此外,该方法在片剂和注射剂中通常存在的赋形剂存在的情况下具有选择性。在合成样品和剂型中的平均回收率为 98.8-103.0%。通过英国药典方法获得了所得结果,并且获得了可比的结果。